Profil
Daniel Goor is the founder of Itamar Medical Ltd., which was founded in 1997.
He also worked as an Inventor, Medical Director & Director at New N.I.
Medical (2011) Ltd.
Anciens postes connus de Daniel Goor
| Sociétés | Poste | Fin |
|---|---|---|
| ITAMAR MEDICAL LTD. | Fondateur | 01/01/2016 |
New N.I. Medical (2011) Ltd.
 New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev. | Directeur/Membre du Conseil | 01/01/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Itamar Medical Ltd.
 Itamar Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets the WatchPAT and EndoPAT products. The WatchPAT diagnoses sleep apnea, a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur in 1995 and is headquartered in Caesarea, Israel. | Electronic Technology |
New N.I. Medical (2011) Ltd.
New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev. | Health Technology |
